Sleep Apnea, Obstructive Completed Phase 2 Trials for Caffeine (DB00201)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00273754The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).Prevention